SecSonar.com

BeOne Medicines Ltd. (ONC)

BeOne Medicines Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

BeOne Medicines Ltd. (ONC) is a Medical - Pharmaceuticals company based in US with a market capitalization of $31B. Revenue grew 40.2% year-over-year and the company generated $941.7M in free cash flow. This page tracks ONC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 11K employees · IPO Feb 2, 2016

Valuation

Valuation & price

$293.27 · as of May 17, 2026 · -22.3% vs 52w high

116.0

P/E ratio

Latest-FY diluted EPS

7.11

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$377$309$241Jul 25Dec 25Jul 26Jul 7, 25$240.99Jul 9, 25$255.69Jul 11, 25$250.30Jul 15, 25$269.70Jul 17, 25$290.35Jul 21, 25$291.93Jul 23, 25$294.83Jul 25, 25$291.47Jul 29, 25$305.74Jul 31, 25$301.13Aug 4, 25$304.30Aug 6, 25$298.52Aug 11, 25$289.75Aug 13, 25$307.51Aug 15, 25$321.36Aug 19, 25$312.51Aug 21, 25$313.97Aug 25, 25$308.63Aug 27, 25$300.14Aug 29, 25$306.05Sep 3, 25$336.26Sep 5, 25$341.80Sep 9, 25$351.13Sep 11, 25$335.67Sep 16, 25$327.20Sep 18, 25$342.89Sep 22, 25$337.82Sep 24, 25$329.84Sep 26, 25$326.06Sep 30, 25$340.70Oct 2, 25$345.17Oct 6, 25$344.53Oct 8, 25$351.09Oct 10, 25$320.10Oct 14, 25$320.94Oct 16, 25$318.02Oct 21, 25$315.74Oct 23, 25$310.03Oct 27, 25$315.43Oct 29, 25$314.85Oct 31, 25$310.48Nov 4, 25$309.19Nov 6, 25$332.36Nov 10, 25$329.20Nov 12, 25$377.47Nov 14, 25$365.82Nov 18, 25$363.92Nov 20, 25$349.29Nov 25, 25$335.17Nov 28, 25$340.61Dec 2, 25$330.19Dec 4, 25$331.40Dec 8, 25$326.49Dec 10, 25$322.68Dec 12, 25$319.06Dec 16, 25$304.31Dec 18, 25$307.02Dec 22, 25$313.36Dec 24, 25$311.73Dec 29, 25$310.30Jan 2, 26$311.02Jan 6, 26$320.35Jan 8, 26$320.37Jan 12, 26$333.99Jan 14, 26$346.75Jan 16, 26$338.19Jan 21, 26$341.64Jan 23, 26$339.32Jan 27, 26$336.16Jan 29, 26$350.00Feb 2, 26$345.00Feb 4, 26$352.00Feb 9, 26$348.85Feb 11, 26$351.27Feb 13, 26$346.07Feb 18, 26$359.05Feb 20, 26$362.14Feb 24, 26$369.00Feb 26, 26$322.37Mar 2, 26$314.36Mar 4, 26$299.02Mar 6, 26$301.12Mar 10, 26$305.39Mar 12, 26$285.30Mar 17, 26$287.33Mar 19, 26$282.72Mar 23, 26$274.73Mar 25, 26$283.45Mar 27, 26$283.03Mar 31, 26$296.97Apr 2, 26$310.79Apr 7, 26$303.82Apr 9, 26$313.42Apr 13, 26$305.64Apr 15, 26$319.94Apr 17, 26$323.87Apr 22, 26$312.41Apr 24, 26$300.80Apr 28, 26$298.16Apr 30, 26$295.27May 4, 26$297.14May 6, 26$313.32May 8, 26$312.12May 12, 26$315.07May 14, 26$304.62May 18, 26$293.09May 20, 26$308.74May 22, 26$310.25May 28, 26$290.58Jun 1, 26$279.68Jun 3, 26$279.00Jun 5, 26$270.10Jun 9, 26$268.17Jun 11, 26$260.27Jun 15, 26$268.20Jun 17, 26$262.68Jun 22, 26$271.80Jun 24, 26$277.12Jun 26, 26$279.89Jul 2, 26$297.65
$240.9952-week range$377.47
Loading valuation history…

Fundamentals

Key fundamentals

$31B

Market cap

40.2%

Revenue growth (YoY)

87.5%

Gross margin

$941.7M

Free cash flow (USD)

-$2.5B

Net debt

Net cash position

3.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$1.1MFY 2017$238.4MFY 2018$198.2MFY 2019$428.2MFY 2020$308.9MFY 2021$1.2BFY 2022$1.4BFY 2023$2.5BFY 2024$3.8BFY 2025$5.3B
$1.1M$5.3B

Free cash flow by year

2016 → 2025

FY 2016$-113.0MFY 2017$-46.0MFY 2018$-688.6MFY 2019$-908.9MFY 2020$-1.5BFY 2021$-1.6BFY 2022$-2.0BFY 2023$-1.8BFY 2024$-669.8MFY 2025$941.7M
-$113M$941.7M

Gross margin by year

2021 → 2025

FY 202186.0%FY 202279.8%FY 202384.5%FY 202484.4%FY 202587.5%
86.0%87.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

25

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventTax SettlementJun 26, 2026Filing
  • Insider sellInsider Sell $296KWang Lai · President, Global Head of R&D · $295.6KJun 25, 2026Filing
  • Insider sellInsider Sell $934KOYLER JOHN · Director, Chief Executive Officer · $933.6KJun 25, 2026Filing
  • Insider sellInsider Sell $357KWu Xiaobin · President and COO · $356.9KJun 25, 2026Filing
  • Insider sellInsider Sell $310KWang Lai · President, Global Head of R&D · $310.2KJun 18, 2026Filing
  • Insider sellInsider Sell $157KLee Chan Henry · SVP, General Counsel · $156.9KJun 18, 2026Filing
  • Insider sellInsider Sell $981KOYLER JOHN · Director, Chief Executive Officer · $980.7KJun 18, 2026Filing
  • Insider sellInsider Sell $362KWu Xiaobin · President and COO · $362KJun 18, 2026Filing
  • Insider sellInsider Sell $501KOYLER JOHN · Director, Chief Executive Officer · $501.4KJun 15, 2026Filing
  • Insider sellInsider Sell $110KLee Chan Henry · SVP, General Counsel · $110.3KJun 15, 2026Filing

Questions

Frequently asked questions

What is BeOne Medicines Ltd.'s market cap?

BeOne Medicines Ltd. (ONC) has a market capitalization of $31B.

What is ONC's P/E ratio?

ONC trades at a price-to-earnings ratio of 116.0, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is ONC's price-to-book (P/B) ratio?

ONC trades at 7.11 times book value per share.

Are insiders buying ONC stock?

SEC Form 4 filings show no open-market insider buys at BeOne Medicines Ltd. in the last 90 days (25 sells).

Same arena

Related companies in Medical - Pharmaceuticals

HITI

High Tide Inc.

$218.4M

LFMD

LifeMD, Inc.

$214.2M

YI

111, Inc.

$47.9M

PETS

PetMed Express, Inc.

$46.7M

SDEV

Stablecoin Development Corp.

$35M

NEUP

Neuphoria Therapeutics Inc.

$28.6M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.